Skip to main content

Abstract

This chapter will attempt to accomplish a seemingly impossible task of characterizing the concept of quality of life in terms of pleasure centres, neuronal circuits and chemical mechanisms in the brain. The supporting explanations will be presented in three parts: first, identifying three key characteristics of quality of life – first, the central doctrine of subjectivity, the time frame of appraisal, and the relevance of immediate affective tone in determining quality of life ratings; second, a review of the cumulative knowledge on the neuroanatomical and neurochemical mechanisms underlying subjective responses to pleasurable stimuli such as food and drugs. Thirdly, evidence is presented to support that interference with these brain reward mechanisms leads to feelings of lack of pleasure and poor quality of life, citing antipsychotic drug therapy in schizophrenia as an example. Laboratory experiments in animals and neurochemical imaging studies in humans suggest that dopaminergic mechanisms in nucleus accumbens, amygdala, hippocampus and prefrontal cortex are key players in determining the qualitative and quantitative aspects of subjective responses to pleasurable stimuli. Antipsychotic drug induced dopaminergic blockade in these neuronal circuits leads to persistent feelings of dysphoria and pervasive lack of pleasure, leading to subjective distress and compromised quality of life. The nuances of subjective responses to antipsychotic drugs thus have enormous implications for long term care of the mentally ill people

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hornquist JO. The concept of quality of life. Scandinavian Journal of Social Medicine. 1982;10:57–61.

    PubMed  CAS  Google Scholar 

  2. Cohen C. On the quality of life: some philosophical reflections. Circulation 1982;66(suppl.111): s29–s33.

    Google Scholar 

  3. Campbell A, Converse P, Rogers W. The quality of American life. New York: Russel Sage Foundation, 1976.

    Google Scholar 

  4. Diener E. Subjective Well-Being. Psychological Bulletin 1984;95(3):542–575.

    Article  PubMed  CAS  Google Scholar 

  5. George L, Bearon I. Quality of life in older persons: meaning and measurement. New York: Human Sciences Press, 1980.

    Google Scholar 

  6. Voruganti L, Heslegrave H, Awad AG & Seeman MV. Quality of life measurement in Schizophrenia – Reconciling the quest for subjectivity with the question of reliability. Psychological Medicine 1998;28:165–172.

    Article  PubMed  CAS  Google Scholar 

  7. Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res. 1997; 6(1):21–6.

    Article  PubMed  CAS  Google Scholar 

  8. Corten P, Mercier C, Pelc I. ‘‘Subjective quality of life’’: clinical model for assessment of rehabilitation treatment in psychiatry. Social Psychiatry and Psychiatric Epidemiology 1994; 29:178-183.

    PubMed  CAS  Google Scholar 

  9. Goethe JW & Fisher EH. Functional impairment in depressed patients. Journal of Affective Disorders, 1995;33: 23–29.

    Article  PubMed  CAS  Google Scholar 

  10. Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients: results from the medical outcomes study. JAMA 1989;262:914–919.

    Article  PubMed  CAS  Google Scholar 

  11. Voruganti LP, Awad AG. Brain imaging research on subjective responses to psychotropic drugs. Acta Psychiatr Scand Suppl. 2005;(427):22–8.

    Article  PubMed  Google Scholar 

  12. Allison PJ, Locker D, Feine JS. Quality of life: a dynamic construct. Social science and medicine 1997;45:221–230.

    Article  PubMed  CAS  Google Scholar 

  13. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 2004; 12(6):305–20.

    Article  PubMed  Google Scholar 

  14. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 1996;6:243–51.

    Article  PubMed  CAS  Google Scholar 

  15. James GA, Gold MS, Liu Y. Interaction of satiety and reward response to food stimulation. J Addict Dis. 2004;23(3):23–37.

    Article  PubMed  Google Scholar 

  16. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403–13.

    Article  PubMed  Google Scholar 

  17. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O’Dell LE, Parsons LH, Sanna PP. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev. 2004;27(8):739–49.

    Article  PubMed  CAS  Google Scholar 

  18. Risinger RC, Salmeron BJ, Ross TJ, Amen SL, Sanfilipo M, Hoffmann RG, Bloom AS, Garavan H, Stein EA. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage. 2005;26(4):1097–108.

    Article  PubMed  Google Scholar 

  19. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47 Suppl 1:3–13.

    Article  PubMed  CAS  Google Scholar 

  20. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology. 2004;47 Suppl 1:227–41.

    PubMed  Google Scholar 

  21. Salamone JD, Correa M, Mingote SM, Weber SM. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol. 2005;5(1):34–41.

    Article  PubMed  CAS  Google Scholar 

  22. Voruganti L, Awad AG. Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology (Berl). 2004;171(2):121–32.

    Article  CAS  Google Scholar 

  23. Voruganti LN, Awad AG. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia – Findings from an in vivo SPECT study. Schizophr Res. 2006 Sep 1; [Epub ahead of print].

    Google Scholar 

  24. Tsibulsky VL, Norman AB. Real time computation of in vivo drug levels during drug self-administration experiments. Brain Res Brain Res Protoc. 2005;15(1):38–45.

    Article  PubMed  CAS  Google Scholar 

  25. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med. 1995;36(7):1182–90.

    PubMed  CAS  Google Scholar 

  26. de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry. 2003;160(2):303–9.

    Article  PubMed  Google Scholar 

  27. Voruganti L, Cortese L, Owyeumi L, Kotteda V, Cernovsky Z, Zirul S, Awad A. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study. Schizophr Res. 2002;57(2–3):201–8.

    Article  PubMed  CAS  Google Scholar 

  28. Voruganti L, Slomka P, Zabel P, Costa G, So A, Mattar A, Awad AG. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging.Neuropsychopharmacology. 2001;25:642–50.

    Article  CAS  Google Scholar 

  29. Koivumaa-Honkanen H-T, Viinamaki H, Honkanen R, Tanskanen A, Antikainen R, Niskanen L, Jaaskelainen J, Lehtonen J, Correlates of Life satisfaction among psychiatric patients. Acta Psychiatrica Scandinavica. 1996;94:372–378.

    PubMed  CAS  Google Scholar 

  30. Awad AG & Voruganti LP. Neuroleptic dysphoria, comorbid drug abuse in schizophrenia and the emerging science of subjective tolerability: towards a new synthesis. J Dual Diagnosis 2005;1(2):83–94.

    Article  Google Scholar 

  31. Lehman A. The well-being of chronic mental patients: assessing their quality of life. Archives of General Psychiatry 1983;40:369–373.

    PubMed  CAS  Google Scholar 

  32. Grace AA. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction. 2000;95 Suppl 2:S119–28.

    Article  PubMed  Google Scholar 

  33. Voruganti LN, Heslegrave RJ, Awad AG. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. J Nerv Ment Dis. 1997;185(7):463–5.

    Article  PubMed  CAS  Google Scholar 

  34. Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res. 2001;107(3):173–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 springer

About this chapter

Cite this chapter

Voruganti, L.N., Awad, A.G. (2007). Role of Dopamine in Pleasure, Reward and Subjective Responses to Drugs. In: Ritsner, M.S., Awad, A.G. (eds) Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5779-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-5779-3_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-5777-9

  • Online ISBN: 978-1-4020-5779-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics